[Pelvic exenteration of advanced gynecological malignacies: a report of 18 cases].
OBJECTIVE
To investigate the role of pelvic exenteration in the treatment of advanced gynecological malignances.


METHODS
Eighteen patients with cervical cancer in 8, vulvar cancer in 8, and vaginal cancer in 2, who underwent pelvic exenteration at the Cancer Hospital of Shanghai Medical University between 1970 and 1990 were retrospectively analyzed.


RESULTS
Median age was 52 years (range 27-65). One woman received surgery of total pelvic exenteration, 10 anterior and 7 posterior exenteration. The 3,5-year survival rates were 72%, 50%, respectively. Postoperative morbidity was 16%, and the surgical mortality was 0%. Bowel obstruction occurred in 2 of 18 cases, one of them was treated surgically.


CONCLUSIONS
(1) Patients with advanced central type pelvic neoplasms can be successfully treated with exenteration; (2) The patients should be properly selected prior to and in operation, and the procedures must be performed specifically, particularly in exploration stage.
Zhang
Z
Z
Department of Gynecological Oncology, Cancer Hospital, Shanghai Medical University, Shanghai 200032, China.
Zang
R
R
Chen
J
J
D000328:Adult; D000368:Aged; D005260:Female; D005833:Genital Neoplasms, Female / Q000401:mortality / Q000601:surgery*; D006801:Humans; D008875:Middle Aged; D010385:Pelvic Exenteration / Q000009:adverse effects; D012189:Retrospective Studies; D015996:Survival Rate